MA54240A - Analogues de composés de diméthoxybenzène, procédés d'analyse desdits composés et produits standard desdits composés - Google Patents

Analogues de composés de diméthoxybenzène, procédés d'analyse desdits composés et produits standard desdits composés

Info

Publication number
MA54240A
MA54240A MA054240A MA54240A MA54240A MA 54240 A MA54240 A MA 54240A MA 054240 A MA054240 A MA 054240A MA 54240 A MA54240 A MA 54240A MA 54240 A MA54240 A MA 54240A
Authority
MA
Morocco
Prior art keywords
compounds
same compounds
dimethoxybenzene
analogs
analysis
Prior art date
Application number
MA054240A
Other languages
English (en)
Inventor
Masaya Hashimoto
Yuji Kanamoto
Kohei Kanda
Reina Ota
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2018/041744 external-priority patent/WO2020095452A1/fr
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of MA54240A publication Critical patent/MA54240A/fr

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/286Phases chemically bonded to a substrate, e.g. to silica or to polymers
    • B01J20/287Non-polar phases; Reversed phases
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/291Gel sorbents
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N2030/022Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027Liquid chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/26Conditioning of the fluid carrier; Flow patterns
    • G01N30/28Control of physical parameters of the fluid carrier
    • G01N30/34Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MA054240A 2018-11-09 2019-11-08 Analogues de composés de diméthoxybenzène, procédés d'analyse desdits composés et produits standard desdits composés MA54240A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/JP2018/041744 WO2020095452A1 (fr) 2018-11-09 2018-11-09 Procédé de fabrication de composé diméthoxybenzène
JP2019044236 2019-03-11

Publications (1)

Publication Number Publication Date
MA54240A true MA54240A (fr) 2021-09-22

Family

ID=70610728

Family Applications (1)

Application Number Title Priority Date Filing Date
MA054240A MA54240A (fr) 2018-11-09 2019-11-08 Analogues de composés de diméthoxybenzène, procédés d'analyse desdits composés et produits standard desdits composés

Country Status (6)

Country Link
US (2) US20210388002A1 (fr)
EP (1) EP3882248A4 (fr)
JP (1) JP7161546B2 (fr)
CN (1) CN113260618A (fr)
MA (1) MA54240A (fr)
WO (2) WO2020096050A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11883404B2 (en) 2016-03-04 2024-01-30 Taiho Pharmaceuticals Co., Ltd. Preparation and composition for treatment of malignant tumors
JP7085985B2 (ja) 2016-03-04 2022-06-17 大鵬薬品工業株式会社 悪性腫瘍治療用製剤及び組成物
CN111867594A (zh) 2018-03-19 2020-10-30 大鹏药品工业株式会社 包含烷基硫酸钠的药物组合物
CN112557571B (zh) * 2020-12-28 2022-11-01 河北合佳医药科技集团股份有限公司 一种伊布替尼原料药制备过程中丙烯酰氯的定量检测方法
CN115785103A (zh) * 2022-12-28 2023-03-14 北京康立生医药技术开发有限公司 一种治疗胆管癌药物福巴替尼的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2657233E (pt) * 2012-01-19 2014-10-24 Taiho Pharmaceutical Co Ltd Composto de alcinil-benzeno substituído nas posições 3 e 5 e um seu sal
DK3023100T3 (da) 2013-07-18 2019-05-27 Taiho Pharmaceutical Co Ltd Antitumorlægemiddel til intermitterende administration af fgfr-hæmmer
JP6084292B2 (ja) 2013-07-18 2017-02-22 大鵬薬品工業株式会社 Fgfr阻害剤耐性癌の治療薬
CN105017256A (zh) * 2014-04-29 2015-11-04 浙江导明医药科技有限公司 多氟化合物作为布鲁顿酪氨酸激酶抑制剂
CN105859721B (zh) * 2015-01-22 2018-04-17 浙江京新药业股份有限公司 一种伊布鲁替尼的制备方法
EP3279202B1 (fr) 2015-03-31 2020-06-24 Taiho Pharmaceutical Co., Ltd. Cristal d'un composé d'alcynyle de benzène 3,5-disubstitué
JP7085985B2 (ja) 2016-03-04 2022-06-17 大鵬薬品工業株式会社 悪性腫瘍治療用製剤及び組成物

Also Published As

Publication number Publication date
US20210388002A1 (en) 2021-12-16
JPWO2020096050A1 (ja) 2021-10-07
US20210387990A1 (en) 2021-12-16
CN113260618A (zh) 2021-08-13
EP3882248A4 (fr) 2022-07-06
WO2020096042A1 (fr) 2020-05-14
EP3882248A1 (fr) 2021-09-22
JP7161546B2 (ja) 2022-10-26
WO2020096050A1 (fr) 2020-05-14

Similar Documents

Publication Publication Date Title
MA54240A (fr) Analogues de composés de diméthoxybenzène, procédés d'analyse desdits composés et produits standard desdits composés
MA46479A (fr) Procédés et intermédiaires pour la préparation de nouveaux composés substitués de 6,7-dihydro-5h-benzo[7]annulène
CL2020001852A1 (es) Procesos de preparación de s-ketamina o clorhidrato de s-ketamina o productos derivados de éste. (divisional solicitud 201901066)
MA49858A (fr) Composés, compositions et procédés
MA49752A (fr) Procédés de préparation de composés de pyrrolidine
MA50063A (fr) Composés, compositions et procédés
MA54953A (fr) Composés, compositions et procédés
MA50347A (fr) Analyse d'un échantillon de roche
MA50045A (fr) Composés spirocycliques et procédés de préparation et d'utilisation de ceux-ci
FR3069360B1 (fr) Procede d'analyse d'une image d'une arcade dentaire
MA54959A (fr) Composés, compositions et procédés
MA48797A (fr) Variants de l'endonucléase cblb , compositions et procédés d'utilisation
MA50041A (fr) Composés spirocycliques et procédés de préparation et d'utilisation de ceux-ci
MA48942A (fr) Composés thérapeutiques, compositions et procédés d'utilisation associés
MA54939A (fr) Hydroxypyridoxazépines utilisées en tant qu'activateurs de nrf2
MY190086A (en) Poultry feed, method for increasing gizzard weight of poultry, and method for rearing poultry
MA55527A (fr) Polynucléotides, compositions et procédés d'expression de polypeptides
MA42527A (fr) Agonistes de récepteur 5-ht2c et compositions et procédés d'utilisation
BR112019003972A2 (pt) máquina de extrusão de massas alimentícias
EP3857203A4 (fr) Procédés de détection d'effet(s) crochet associé(s) à un (des) analytes d'intérêt pendant la conductance de dosage(s) diagnostique(s) ou résultant de cette conductance
MA52796A (fr) Compositions et procédés de détection d'une lésion cérébrale traumatique
EP3793550A4 (fr) Composés 2,2'-bipyrimidinyl substitués, analogues de ceux-ci, et procédés les utilisant
FR3031502B1 (fr) Ensemble de pointage d'un instrument
MA44680A (fr) Compositions et procédés pour la production de composés
MA53603A (fr) Procédés de modulation de la cytotoxicité à médiation cellulaire dépendante des anticorps